Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Indication for NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer [Yahoo! Finance]
Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
213,285 Orion Corporation A shares converted into B shares [Yahoo! Finance]
Inside information: Orion upgrades full-year outlook for 2024 [Yahoo! Finance]